Overall, average levels of total cholesterol, triglycerides and low­density lipoprotein cholesterol have continued to decline post-2010, according to a study published in JAMA Cardiology. Researchers ...

Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...

In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three ...

Lowering cholesterol is one of the most effective ways to reduce your risk of heart disease, and it may soon be possible to get a one-and-done gene therapy to keep cholesterol and triglyceride levels ...

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...

Every time you get a lipid profile test, a doctor is likely to check for your cholesterol and triglyceride levels. While both of these lipids, or fats, found in the blood increase the risk of heart ...

Start your day with these heart-healthy breakfast options to help improve your cholesterol, according to dietitians.

CARDIO—AEROBIC ACTIVITIES like walking, running, swimming, and cycling—not only reduces total cholesterol, LDL, vLDL and ...